Biotricity, Inc., a medical diagnostic and consumer healthcare technology company, focuses on providing biometric data monitoring solutions in the United States. The company focuses to deliver remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It is developing Bioflux mobile cardiac telemetry solution that provides recurring reimbursements to doctors, hospitals, and independent diagnostic testing facilities; revenue model that fits within the established insurance billing practices; built-in cellular connectivity; and motion tracking to detect exercise, activity, and disorientation. The company is also developing Biolife, a health and lifestyle solution for individuals. It has a collaboration agreement with the University of Calgary to determine the predictive value of electrocardiogram readings in preventative healthcare applications. Biotricity, Inc. is based in Redwood City, California.
Industry, Sector and Symbol
Industry Electric services
Sub-IndustryN/A
SectorMedical
WebN/A
PhoneN/A
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Biotricity (OTCMKTS:BTCY) Frequently Asked Questions
What is Biotricity's stock symbol?
Biotricity trades on the OTCMKTS under the ticker symbol "BTCY."
Has Biotricity been receiving favorable news coverage?
Media headlines about BTCY stock have been trending negative recently, according to InfoTrie. The research group identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Biotricity earned a news impact score of -2.3 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Biotricity.
Who are some of Biotricity's key competitors?
What other stocks do shareholders of Biotricity own?
Who are Biotricity's key executives?
Biotricity's management team includes the folowing people:
- Mr. Waqaas Al-Siddiq, Founder, Pres, CEO & Chairman (Age 34)
- Mr. John Ayanoglou, Chief Financial Officer (Age 53)
- Mr. Casey Shattuck, Global VP of Sales
- Mr. Amir Ali, Chief Devel. Officer
- Mr. Spencer LaDow, VP of Engineering
How do I buy shares of Biotricity?
Shares of BTCY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Biotricity's stock price today?
One share of BTCY stock can currently be purchased for approximately $1.94.
How big of a company is Biotricity?
MarketBeat Community Rating for Biotricity (OTCMKTS BTCY)
MarketBeat's community ratings are surveys of what our community members think about Biotricity and other stocks. Vote "Outperform" if you believe BTCY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BTCY will underperform the S&P 500 over the long term. You may vote once every thirty days.
